Patent · US Active

Mutant pores

US9751915B2 · kind B2 · utility

35Cited by
27References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2012
Grant dateSep 5, 2017
Priority date
Expiry dateMay 4, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K39/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to mutant forms of Msp. The invention also relates to nucleic acid characterization using Msp.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.